Skip to main
ATAI
ATAI logo

Atai Life Sciences BV (ATAI)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy ATAI Stock

About Atai Life Sciences BV (ATAI)

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.
Market cap$439.65M
Today's volume51.37M
Revenue (TTM)$331K
Avg. daily volume2.17M
EBITDA (TTM)-$105.53M
Open$2.63
Price / earnings ratio-2.72x
Today's range$2.36 - $2.9
Debt / equity19.05x
52 week range$1.03 - $2.64
5 year debt / equity5.57x
Beta (LTM)1.52x
Interest coverage-32.87x
Dividend & yield$0.00 (0.00%)
Current ratio4.07x
Ex-dividend date
Next earningsAug 12, 2025
Dividend payable date

ATAI Stock Rating

What analysts recommend for ATAI stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 71%
Buy 24%
Hold 6%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for ATAI stock is $439.65M

The current P/E ratio for ATAI stock is -2.72

The 52-week high for ATAI stock is $2.64. The current ATAI stock price $undefined is 100.00% below its 52-week high

The 52-week low for ATAI stock is $1.03. The current ATAI stock price $undefined has increased 100.00% from its 52-week low

No, the ATAI stock does not pay dividends to its shareholders

The target price for ATAI stock is $18.76 based on the average of what a group of analyst think ATAI stock could be worth at a future date. This is not a prediction by Public.com

How to buy ATAI stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ATAI stock

    Navigate to the Explore page. Then, type ATAI into the search bar. When you see ATAI stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ATAI stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Atai Life Sciences BV Stock Earnings

The value each ATAI share was expected to gain vs. the value that each ATAI share actually gained.

ATAI (ATAI) reported Q1 2025 earnings per share (EPS) of -$0.15, beating estimates of -$0.18 by 16.67%. In the same quarter last year, ATAI's earnings per share (EPS) was -$0.17. ATAI is expected to release next earnings on 08/12/2025, with an earnings per share (EPS) estimate of -$0.10.

Buy ATAI Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.